Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2-3 Study of Silymarin on Cisplatin Induced Nephrotoxicity

NCT01829178 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.

NCT NCT01829178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01829178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2-3 Study of Silymarin on Cisplatin Induced Nephrotoxicity
Lead sponsor
Tehran University of Medical Sciences
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2013
Completion date
September 30, 2014
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cisplatin adverse reaction, upper gi cancer